These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 38455038)
1. Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance. Reyes ME; Pulgar V; Vivallo C; Ili CG; Mora-Lagos B; Brebi P Front Immunol; 2024; 15():1347530. PubMed ID: 38455038 [TBL] [Abstract][Full Text] [Related]
2. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520 [TBL] [Abstract][Full Text] [Related]
3. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect? Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling. Yan W; Wu K; Herman JG; Brock MV; Zhou Y; Lu Y; Zhang Z; Yang Y; Guo M J Cell Mol Med; 2014 Dec; 18(12):2499-511. PubMed ID: 24912879 [TBL] [Abstract][Full Text] [Related]
5. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review. Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236 [TBL] [Abstract][Full Text] [Related]
6. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer. Wu S; Xie J; Shi H; Wang ZW Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression. Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718 [TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy. Spirina LV; Avgustinovich AV; Afanas'ev SG; Cheremisina OV; Volkov MY; Choynzonov EL; Gorbunov AK; Usynin EA Curr Drug Targets; 2020; 21(7):713-721. PubMed ID: 31775598 [TBL] [Abstract][Full Text] [Related]
9. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840 [TBL] [Abstract][Full Text] [Related]
10. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer. Luo M; Deng X; Chen Z; Hu Y Cell Death Dis; 2023 Jan; 14(1):10. PubMed ID: 36624091 [TBL] [Abstract][Full Text] [Related]
12. An integrative approach identified genes associated with drug response in gastric cancer. Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway. Zhang JX; Xu Y; Gao Y; Chen C; Zheng ZS; Yun M; Weng HW; Xie D; Ye S Mol Cancer; 2017 Jan; 16(1):18. PubMed ID: 28114937 [TBL] [Abstract][Full Text] [Related]
14. The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance. Zhu X; Liu J; Xu X; Zhang C; Dai D Int J Oncol; 2015 Jan; 46(1):195-204. PubMed ID: 25355626 [TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer. Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960 [TBL] [Abstract][Full Text] [Related]
16. DNA and histone methylation in gastric carcinogenesis. Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412 [TBL] [Abstract][Full Text] [Related]
17. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer. Wang MQ; Chen YR; Xu HW; Zhan JR; Suo DQ; Wang JJ; Ma YZ; Guan XY; Li Y; Zhu SL Cancer Sci; 2023 Apr; 114(4):1365-1377. PubMed ID: 36519789 [TBL] [Abstract][Full Text] [Related]
20. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2. Li H; Ma X; Yang D; Suo Z; Dai R; Liu C J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]